148 related articles for article (PubMed ID: 23804268)
1. Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.
Petzold C; Schallenberg S; Stern JN; Kretschmer K
Rev Diabet Stud; 2012; 9(4):305-18. PubMed ID: 23804268
[TBL] [Abstract][Full Text] [Related]
2. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells.
Schildknecht A; Brauer S; Brenner C; Lahl K; Schild H; Sparwasser T; Probst HC; van den Broek M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):199-203. PubMed ID: 20018763
[TBL] [Abstract][Full Text] [Related]
3. Inflammation & autoimmunity in human ageing: dendritic cells take a center stage.
Gupta S; Agrawal A
Indian J Med Res; 2013 Nov; 138(5):711-6. PubMed ID: 24434323
[TBL] [Abstract][Full Text] [Related]
4. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.
Dhodapkar MV; Sznol M; Zhao B; Wang D; Carvajal RD; Keohan ML; Chuang E; Sanborn RE; Lutzky J; Powderly J; Kluger H; Tejwani S; Green J; Ramakrishna V; Crocker A; Vitale L; Yellin M; Davis T; Keler T
Sci Transl Med; 2014 Apr; 6(232):232ra51. PubMed ID: 24739759
[TBL] [Abstract][Full Text] [Related]
5. DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.
Mukherjee G; Geliebter A; Babad J; Santamaria P; Serreze DV; Freeman GJ; Tarbell KV; Sharpe A; DiLorenzo TP
Int Immunol; 2013 Nov; 25(11):651-60. PubMed ID: 24021877
[TBL] [Abstract][Full Text] [Related]
6. The Application of Nanovaccines in Autoimmune Diseases.
Tang Y; Li L
Int J Nanomedicine; 2024; 19():367-388. PubMed ID: 38229706
[TBL] [Abstract][Full Text] [Related]
7. Selective ablation of thymic and peripheral Foxp3
Yilmazer A; Zevla DM; Malmkvist R; Rodríguez CAB; Undurraga P; Kirgin E; Boernert M; Voehringer D; Kershaw O; Schlenner S; Kretschmer K
Front Immunol; 2023; 14():1298938. PubMed ID: 38164128
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of autoantigen to dendritic cells prevents development of spontaneous uveitis.
Klaska IP; Yu T; Fordyce R; Kamoi K; Cornall RJ; Martin-Granados C; Kuffova L; Forrester JV
Front Immunol; 2023; 14():1227633. PubMed ID: 37727784
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.
Mollé LM; Smyth CH; Yuen D; Johnston APR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1809. PubMed ID: 36416028
[TBL] [Abstract][Full Text] [Related]
10. Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.
Puricelli C; Boggio E; Gigliotti CL; Stoppa I; Sutti S; Rolla R; Dianzani U
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145531
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function.
Martinek J; Lin J; Kim KI; Wang VG; Wu TC; Chiorazzi M; Boruchov H; Gulati A; Seeniraj S; Sun L; Marches F; Robson P; Rongvaux A; Flavell RA; George J; Chuang JH; Banchereau J; Palucka K
Cell Rep Med; 2022 May; 3(5):100621. PubMed ID: 35584631
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis.
Piacente F; Bottero M; Benzi A; Vigo T; Uccelli A; Bruzzone S; Ferrara G
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457169
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y
Front Immunol; 2021; 12():643240. PubMed ID: 33679806
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.
Kammona O; Kiparissides C
Brain Sci; 2020 May; 10(6):. PubMed ID: 32486045
[TBL] [Abstract][Full Text] [Related]
15. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
16. New insight into type 1 diabetes development: resolving early diabetogenic CD4
Schallenberg S; Kretschmer K
Ann Transl Med; 2018 Feb; 6(3):58. PubMed ID: 29610749
[No Abstract] [Full Text] [Related]
17. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
Front Immunol; 2018; 9():125. PubMed ID: 29456534
[TBL] [Abstract][Full Text] [Related]
18. Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.
Rapoport EM; Khaidukov SV; Gaponov AM; Pazynina GV; Tsygankova SV; Ryzhov IM; Belyanchikov IM; Milona P; Bovin NV; McCullough KC
Glycoconj J; 2018 Apr; 35(2):191-203. PubMed ID: 29388006
[TBL] [Abstract][Full Text] [Related]
19. Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.
Yu C; Xi J; Li M; An M; Liu H
Bioconjug Chem; 2018 Mar; 29(3):719-732. PubMed ID: 29165988
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
